← FDA Drug Approvals (Drugs@FDA)
BIVALIRUDIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN INSTITUTIONAL · Approved 2018-06-01
Drug application
- FDA Application #
ANDA202471- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BIVALIRUDIN
- Generic name
- BIVALIRUDIN
- Active ingredients
- BIVALIRUDIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- MYLAN INSTITUTIONAL
- Manufacturer
- Mylan Institutional LLC
- First approval
- 2018-06-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown